Page last updated: 2024-12-11

11,12-dihydroxyeicosatetraenoic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

## 11,12-Dihydroxyeicosatetraenoic Acid (11,12-DiHETE): A Crucial Player in Inflammation

**11,12-DiHETE** is a specific **metabolite** of **arachidonic acid**, a fatty acid found in cell membranes. It is produced through the **lipoxygenase pathway** by the enzyme **12-lipoxygenase**.

This molecule is crucial for research due to its role in various biological processes, particularly **inflammation**. Here's why it's important:

**1. Pro-Inflammatory Mediator:**

* 11,12-DiHETE acts as a potent **pro-inflammatory** mediator, meaning it contributes to the development and progression of inflammation.
* It achieves this by promoting the release of other inflammatory mediators like **cytokines** and **chemokines**.
* This makes it a crucial target for research aiming to understand and treat inflammatory diseases.

**2. Role in Various Diseases:**

* **Asthma:** 11,12-DiHETE is found in high levels in the airways of asthmatic patients, suggesting a potential role in disease pathogenesis.
* **Cancer:** Studies have shown its involvement in the growth and metastasis of certain cancers, particularly those affecting the colon and breast.
* **Neurological Disorders:** 11,12-DiHETE has been implicated in the development of neurodegenerative diseases like Alzheimer's and Parkinson's.

**3. Research Targets:**

* **Drug Development:** 11,12-DiHETE's pro-inflammatory role has led to research focused on developing drugs that inhibit its formation or block its effects. This could be a promising strategy for treating inflammatory diseases.
* **Biomarker Discovery:** Identifying and measuring 11,12-DiHETE levels could be useful for diagnosing and monitoring certain diseases.
* **Mechanistic Understanding:** Researching the molecular mechanisms underlying 11,12-DiHETE's actions can provide insights into how inflammation and other disease processes occur.

**4. Potential for Therapeutic Applications:**

* **Anti-inflammatory therapy:** Inhibiting 11,12-DiHETE production or blocking its activity could potentially reduce inflammation in various conditions.
* **Cancer treatment:** Targeting the production of 11,12-DiHETE or its signaling pathways could offer a new avenue for cancer treatment.

**Overall, 11,12-DiHETE is a fascinating molecule with significant implications for research in inflammation, cancer, and neurodegenerative disorders. Its role as a pro-inflammatory mediator and potential therapeutic target makes it a crucial area of ongoing scientific exploration.**

11,12-dihydroxyeicosatetraenoic acid: formed in human platelets [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID6439109
MeSH IDM0152420

Synonyms (6)

Synonym
11,12-dihydroxyeicosatetraenoic acid
(2e,4e,6e,8e)-11,12-dihydroxyicosa-2,4,6,8-tetraenoic acid
11,12-dhete
eicosatetraenoic acid, 11,12-dihydroxy-
122087-32-5
11,12-dihydroxy-eicosatetraenoic acid
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (7)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (28.57)18.7374
1990's2 (28.57)18.2507
2000's1 (14.29)29.6817
2010's2 (28.57)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.59

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.59 (24.57)
Research Supply Index2.08 (2.92)
Research Growth Index4.66 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.59)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other7 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]